Unilateral Cutaneous Ureterostomy - Long Term Follow up - Full Text View

Unilateral Cutaneous Ureterostomy - Long Term Follow up (ureterostomy)

This study is currently recruiting participants.
Verified by Sheba Medical Center, March 2008

Sponsored by:	Sheba Medical Center
Information provided by:	Sheba Medical Center
ClinicalTrials.gov Identifier:	NCT00546208

Purpose

This observational study is aimed at exploring bladder function following temporary unilateral low loop cutaneous ureterostomy carried out in newborns suffering from severe congenital hydro-ureteronephrosis

Condition

Bladder Function

U.S. FDA Resources

Study Type:	Observational
Study Design:	Other, Prospective

Official Title:	Bladder Function Following Temporary Unilateral Cutaneous Ureterostomy - Long Term Follow up

Further study details as provided by Sheba Medical Center:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	30
Study Start Date:	February 2008

Groups/Cohorts

adolescents and young adults who underwent, as newborns, unilateral low loop cutaneous ureterostomy for severe bilateral hydro-ureteronephrosis, and that, afterwards, underwent stomal closure

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

adolescents and adults who had been operated in our institution for severe bilateral congenital hydro-ureteronephrosis

Criteria

Inclusion Criteria:

Living patients
Bilateral functioning kidneys
Unilateral ureteral cutaneous diversion

Exclusion Criteria:

Dead patients
Single kidney
High percutaneous ureteral diversion (e.g: cutaneous pyelostomies, bilateral cutaneous urinary diversion)

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00546208

Contacts


Contact: Dorit E Zilberman, MD	+97235302231	dorit.zilberman@sheba.health.gov.il

Locations


Israel
	The Chaim Sheba Medical Center, Tel Hashomer	Recruiting
	Ramat Gan, Israel, 52621
	Contact: Dorit E Zilberman, MD +973-3-5302231 dorit.zilberman@sheba.health.gov.il
	Sub-Investigator: Yoram Mor, MD

Sponsors and Collaborators

Sheba Medical Center

Investigators


Principal Investigator:	Dorit E Zilberman, MD	The Chaim Sheba Medical Center

More Information

Responsible Party:	Urology Department, Chaim Sheba Medical Center ( Dorit Zilberman )
Study ID Numbers:	SHEBA-07-4838-DZ-CTIL
First Received:	October 17, 2007
Last Updated:	March 13, 2008
ClinicalTrials.gov Identifier:	NCT00546208
Health Authority:	Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Sheba Medical Center:

bladder function

cutaneous ureterostomy

hydronephrosis

Study placed in the following topic categories:

Hydronephrosis

ClinicalTrials.gov processed this record on September 05, 2008